Latest news with #MAO


See - Sada Elbalad
06-04-2025
- Entertainment
- See - Sada Elbalad
NJPW Announces 2025 Best if Super Jr. Tournament Participants
Rana Atef On Saturday, New Japan Pro-Wrestling officially announced the 32nd annual Best of the Super Juniors tournament. The tournament will kick off on May 9 in Chiba, with the finals taking place on June 1 at Ota City General Gymnasium. This year will witness the participation of several superstars from different promotions. Kevin Night will participate in the tournament for the first time under the slogan of AEW. Night was announced as an AEW star a few days ago. AEW promising star Nick Wayne will also participate in this year's tournament. MAO will represent DDT, while Dragon Dia will represent DragonGate. There a mysterious CMLL opponent is set for the tournament. Last year's tournament saw El Desperado win the tournament. A Block: El Desperado Ryusuke Taguchi YOH Master Wato KUSHIDA Kevin Knight Ninja Mack Kosei Fujita Robbie Eagles Hiromu Takahashi B Block: BUSHI Francesco Akira Taiji Ishimori Clark Connors SHO Yoshinobu Kanemaru Dragon Dia (Dragongate) MAO (DDT) Nick Wayne (AEW) Mystery Competitor (CMLL) read more Japan Stun Spain 2-1 to Qualify for World Cup Last 16 World Cup 2022: Get to Know Confirmed Line-ups of Japan and Spain Group E Decider Saudi Arabia Bid Farewell to World Cup after 2-1 Loss to Mexico Tunisia Achieve Historic Win over France but Fail to Qualify Tunisia to Clash against France in World Cup Sports Get to Know Squad of Group D Teams in World Cup Sports Al Ahly Gift EGP 70,000 to Players After Claiming Egyptian Super Cup Title Sports Bencharki Hits First 2 Goals with Al Jazira Since Leaving Zamalek Sports Arsenal Possible Line-up for Nottingham Forest News Egypt confirms denial of airspace access to US B-52 bombers News Ayat Khaddoura's Final Video Captures Bombardment of Beit Lahia News Australia Fines Telegram $600,000 Over Terrorism, Child Abuse Content Lifestyle Pistachio and Raspberry Cheesecake Domes Recipe Arts & Culture Nicole Kidman and Keith Urban's $4.7M LA Home Burglarized Videos & Features Bouchra Dahlab Crowned Miss Arab World 2025 .. Reem Ganzoury Wins Miss Arab Africa Title (VIDEO) News Israeli PM Diagnosed with Stage 3 Prostate Cancer Sports Neymar Announced for Brazil's Preliminary List for 2026 FIFA World Cup Qualifiers News Prime Minister Moustafa Madbouly Inaugurates Two Indian Companies Arts & Culture New Archaeological Discovery from 26th Dynasty Uncovered in Karnak Temple


Associated Press
31-01-2025
- Health
- Associated Press
Kidney Care Partners Submits Comments on CMS CY26 Medicare Advantage and Part D Advance Notice
Kidney Care Partners (KCP) – the nation's leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers, and manufacturers – recently submitted comments to the Centers for Medicare & Medicaid Services (CMS) in response to its calendar year (CY) 2026 policy and payment proposals for Medicare Advantage Organizations (MAOs). Given more than half of Medicare beneficiaries have opted into Medicare Advantage plans, KCP appreciates that plan products offered by MAOs are available to patients with kidney failure. Such plans often provide supplemental benefits and services that traditional Medicare does not. These benefits can be especially impactful to patient well-being, including care coordination, nutrition support, healthy grocery allowances, and transportation services. However, KCP is concerned that MAO plan products may not provide timely access to benefits that patients in traditional Medicare receive, including access to innovative and breakthrough drugs, biologicals, and devices. In its comments, KCP urged CMS to expand access to innovations for individuals living with kidney failure – or end-stage renal disease (ERSD) enrolled in MAO health plans – by reimbursing dialysis care providers directly for special payments associated with Transitional Drug Add-on Payment Adjustment (TDAPA) or Transitional Add-on Payment Adjustment for New and Innovative Equipment and Suppliers (TPNIES) programs, to ensure access to innovative therapies, equipment and supplies prescribed by a patient's physician. Currently, CMS does not require MAO plan products to reimburse dialysis facilities for innovative therapies, equipment and supplies that are part of the CMS' TDAPA or TPNIES programs, leaving patients enrolled in the MA program at a potential clinical disadvantage from their counterparts enrolled in traditional Medicare. Further, KCP specifically urged CMS to ensure access to TDAPA payment for phosphate binders that were incorporated into the End-Stage Renal Disease Prospective Payment System (ESRD PPS) at the beginning of the year. 'Given the critical nature of these products in the effective management of individuals' phosphate levels, the potential lack of access to the TDAPA adjustment during the two-year transition period could result in a de facto lack of coverage and lead to increased patient morbidity and mortality,' the letter read. 'Those across the kidney disease continuum should be supported by health coverage plans that meet their needs, improve quality of life and provide easy access to care,' said Mahesh Krishnan, MD, MPH, MBA, Chair of KCP. 'KCP looks forward to working with CMS to implement policies that improve the care for kidney patients in MA plans and ensure all beneficiaries can access comprehensive care and timely access to innovative treatments.' Sarah Feagan 616-560-2059